Human Genome Epidemiology Literature Finder
|
Records 1 - 25 (of 25 Records) |
| Query Trace: Carcinoma and FGFR4[original query] |
|---|
| Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer research 2002 Feb 62 (3): 840-7. Bange Johannes, Prechtl Dieter, Cheburkin Yuri, Specht Katja, Harbeck Nadia, Schmitt Manfred, Knyazeva Tatjana, Müller Susanne, Gärtner Silvia, Sures Irmi, Wang Hongyang, Imyanitov Evgeny, Häring Hans-Ulrich, Knayzev Pjotr, Iacobelli Stefano, Höfler Heinz, Ullrich Ax |
| Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma. Cancer 2003 Nov 98 (10): 2245-50. Morimoto Yuki, Ozaki Toshifumi, Ouchida Mamoru, Umehara Norifumi, Ohata Norihide, Yoshida Aki, Shimizu Kenji, Inoue Haji |
| FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer. Oncology reports 2005 Aug 14 (2): 415-9. Spinola Monica, Leoni Vera Piera, Tanuma Jun-Ichi, Pettinicchio Angela, Frattini Milo, Signoroni Stefano, Agresti Roberto, Giovanazzi Riccardo, Pilotti Silvana, Bertario Lucio, Ravagnani Fernando, Dragani Tommaso |
| The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma. Experimental and molecular pathology 2007 Feb 82 (1): 53-7. da Costa Andrade Valéria Cristina, Parise Orlando, Hors Cora Pereira, de Melo Martins Poliana Cristina, Silva Alexandre Pacheco, Garicochea Bernar |
| Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer. Oral oncology 2009 Jan 45 (1): 23-9. Ansell Anna, Farnebo Lovisa, Grénman Reidar, Roberg Karin, Thunell Lena |
| Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. Journal of hepatology 2009 Jan 50 (1): 118-27. Ho Han Kiat, Pok Sharon, Streit Sylvia, Ruhe Jens E, Hart Stefan, Lim Kah Suan, Loo Hooi Linn, Aung Myat Oo, Lim Seng Gee, Ullrich Ax |
| Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study. BMC cancer 2009 9 (1): 172. Nan Hongmei, Qureshi Abrar A, Hunter David J, Han Jia |
| FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. International journal of cancer. Journal international du cancer 2009 Jun 124 (12): 2880-5. Falvella Felicia S, Frullanti Elisa, Galvan Antonella, Spinola Monica, Noci Sara, De Cecco Loris, Nosotti Mario, Santambrogio Luigi, Incarbone Matteo, Alloisio Marco, Calabrò Elisa, Pastorino Ugo, Skaug Vidar, Haugen Aage, Taioli Emanuela, Dragani Tommaso |
| FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma. Oncology reports 2010 Mar 23 (3): 739-44. Tanuma Jun-Ichi, Izumo Toshiyuki, Hirano Masato, Oyazato Yoshitaka, Hori Fumiya, Umemura Eri, Shisa Hayase, Hiai Hiroshi, Kitano Mot |
| Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma. Molecular carcinogenesis 2012 Jul 51 (7): 515-21. Yang Yuan, Zhou Yun, Lu Ming, An Yu, Li Rui, Chen Yao, Lu Da-Ru, Jin Li, Zhou Wei-Ping, Qian Ji, Wang Hong-Ya |
| HFE, MTHFR, and FGFR4 genes polymorphisms and breast cancer in Brazilian women. Molecular and cellular biochemistry 2011 Nov 357 (1-2): 247-53. Batschauer Anna P, Cruz Nathalia G, Oliveira Vanessa C, Coelho Fernanda F, Santos Izabela R, Alves Michelle T, Fernandes Ana P, Carvalho Maria G, Gomes Karina |
| FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx. PloS one 2012 7 (11): e50747. Dutra Roberta Lelis, de Carvalho Marcos Brasilino, Dos Santos Marcelo, Mercante Ana Maria da Cunha, Gazito Diana, de Cicco Rafael, Group Gencapo, Tajara Eloiza Helena, Louro Iúri Drumond, da Silva Adriana Madeira Álvar |
| Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients. International journal of cancer. Journal international du cancer 2013 Oct 133 (8): 1994-2003. Farnebo Lovisa, Tiefenböck Katharina, Ansell Anna, Thunell Lena K, Garvin Stina, Roberg Kar |
| The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy. Cancer research and treatment : official journal of Korean Cancer Association 2015 May . Shim Hyun-Jeong, Shin Min-Ho, Kim Hee-Nam, Kim Jo-Heon, Hwang Jun-Eul, Bae Woo-Kyun, Chung Ik-Joo, Cho Sang-H |
| Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. PloS one 2015 10 (4): e0122961. Sheu Ming-Jen, Hsieh Ming-Ju, Chiang Whei-Ling, Yang Shun-Fa, Lee Hsiang-Lin, Lee Liang-Ming, Yeh Chao-B |
| FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma. Pathobiology : journal of immunopathology, molecular and cellular biology 2015 82 (6): 280-9. Koole Koos, van Kempen Pauline M W, van Bockel Liselotte W, Smets Timo, van der Klooster Zoë, Dutman Annemiek C, Peeters Ton, Koole Ron, van Diest Paul, van Es Robert J J, Willems Stefan |
| FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Cancer science 2016 Sep . Hibi Masaaki, Kaneda Hiroyasu, Tanizaki Junko, Sakai Kazuko, Togashi Yosuke, Terashima Masato, De Velasco Marco Antonio, Fujita Yoshihiko, Banno Eri, Nakamura Yu, Takeda Masayuki, Ito Akihiko, Mitsudomi Tetsuya, Nakagawa Kazuhiko, Okamoto Isamu, Nishio Kazu |
| Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility. Oncotarget 2017 Nov 8 (56): 96225-96238. Chou Chia-Hsuan, Hsieh Ming-Ju, Chuang Chun-Yi, Lin Jen-Tsun, Yeh Chia-Ming, Tseng Pao-Yu, Yang Shun-Fa, Chen Mu-Kuan, Lin Chiao-W |
| Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. World journal of clinical oncology 2019 Mar 10 (3): 136-148. Wimmer Eva, Ihrler Stephan, Gires Olivier, Streit Sylvia, Issing Wolfgang, Bergmann Christo |
| Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study. Liver cancer 2019 3 8 (1): 12-23. Kang Hyo Jeong, Haq Farhan, Sung Chang Ohk, Choi Jene, Hong Seung-Mo, Eo Soo-Heang, Jeong Hui Jeong, Shin Jinho, Shim Ju Hyun, Lee Han Chu, An Jihyun, Kim Mi-Ju, Kim Kyu-Pyo, Ahn Sung-Min, Yu Euns |
| Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma. International journal of environmental research and public health 2019 Dec 17 (1): . Tsay Ming-Dow, Hsieh Ming-Ju, Lee Chia-Yi, Wang Shian-Shiang, Chen Chuan-Shu, Hung Sheng-Chun, Lin Chia-Yen, Yang Shun- |
| Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib. Scientific reports 2020 Oct 10 (1): 17054. Azuma Shintaro, Uojima Haruki, Chuma Makoto, Shao Xue, Hidaka Hisashi, Nakazawa Takahide, Kondo Masaaki, Numata Kazushi, Iwabuchi Shogo, Kako Makoto, Maeda Shin, Koizumi Wasaburo, Atsuda Koichi |
| High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid. Endocrine pathology 2021 7 32 (3): 336-346. Bae Ja-Seong, Jung Seung-Hyun, Hirokawa Mitsuyoshi, Bychkov Andrey, Miyauchi Akira, Lee Sohee, Chung Yeun-Jun, Jung Chan Kw |
| Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer. Scientific reports 2021 Jan 11 (1): 1373. Peng Tao, Sun Yangyang, Lv Zhiwei, Zhang Ze, Su Quanxin, Wu Hao, Zhang Wei, Yuan Wei, Zuo Li, Shi Li, Zhang Li-Feng, Zhou Xiaoli, Mi Yuanyu |
| Whole-exome sequencing reveals candidate high-risk susceptibility genes for endometriosis. Human genomics 2023 10 17 (1): 88. Susanna Nousiainen, Outi Kuismin, Siiri Reinikka, Roosa Manninen, Sara Khamaiseh, Mari Kuivalainen, Anna Terho, Sari Koivurova, Maarit Niinimäki, Kari Salokas, Markku Varjosalo, Anne Ahtikoski, Ralf Bützow, Outi Lindgren, Outi Uimari, Pia Vahteris |
- Page last reviewed:Feb 1, 2024
- Content source: